These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27612279)

  • 21. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
    Ong EL; Goldacre R; Goldacre M
    Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease, multiple sclerosis and changes of residence in Alberta.
    Yiannakoulias N; Schopflocher DR; Warren SA; Svenson LW
    Can J Neurol Sci; 2007 Aug; 34(3):343-8. PubMed ID: 17803035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease.
    Driver JA; Logroscino G; Buring JE; Gaziano JM; Kurth T
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1260-5. PubMed ID: 17548694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: cohort mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the manufacture of electrical capacitors, 1940-1998.
    Prince MM; Hein MJ; Ruder AM; Waters MA; Laber PA; Whelan EA
    Environ Health; 2006 May; 5():13. PubMed ID: 16716225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
    Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
    Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbid cancer in Parkinson's disease.
    Lo RY; Tanner CM; Van Den Eeden SK; Albers KB; Leimpeter AD; Nelson LM
    Mov Disord; 2010 Sep; 25(12):1809-17. PubMed ID: 20669266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-cause mortality following a cancer diagnosis amongst multiple sclerosis patients: a Swedish population-based cohort study.
    Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
    Eur J Neurol; 2015 Jul; 22(7):1074-80. PubMed ID: 25903644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
    Cochrane GD; Rizvi S; Abrantes A; Crabtree B; Cahill J; Friedman JH
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1145-7. PubMed ID: 26307481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
    Cochrane GD; Rizvi S; Abrantes AM; Crabtree B; Cahill J; Friedman JH
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1093-5. PubMed ID: 26228083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study.
    Nuyen J; Schellevis FG; Satariano WA; Spreeuwenberg PM; Birkner MD; van den Bos GA; Groenewegen PP
    J Clin Epidemiol; 2006 Dec; 59(12):1274-84. PubMed ID: 17098570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis and Parkinson's disease: the two faces of neurodegeneration. Report of the first Greek case and review of the literature.
    Bougea A; Kapaki E; Paraskevas GP; Kilidireas K; Andreadou E
    Neurol Sci; 2015 Dec; 36(12):2281-5. PubMed ID: 26134747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
    Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
    Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Parkinson's disease and subsequent cancer risk in Taiwan: a nationwide population-based cohort study.
    Sun LM; Liang JA; Chang SN; Sung FC; Muo CH; Kao CH
    Neuroepidemiology; 2011; 37(2):114-9. PubMed ID: 21986194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of the incidence and prevalence of cancer in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Trojano M; Sorensen PS; Reingold SC; Cutter G
    Mult Scler; 2015 Mar; 21(3):294-304. PubMed ID: 25533302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender and autoimmune comorbidity in multiple sclerosis.
    Magyari M; Koch-Henriksen N; Pfleger CC; Sørensen PS
    Mult Scler; 2014 Aug; 20(9):1244-51. PubMed ID: 24500604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The link between Parkinson's disease and breast and prostate cancers: A meta-analysis.
    Wang T
    Int J Neurosci; 2015; 125(12):895-903. PubMed ID: 25387067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin cancer and Parkinson's disease.
    Ferreira JJ; Neutel D; Mestre T; Coelho M; Rosa MM; Rascol O; Sampaio C
    Mov Disord; 2010 Jan; 25(2):139-48. PubMed ID: 20063399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A rare clinical case of comorbidity of early-onset Parkinson's disease and remitting multiple sclerosis].
    Katunina EA; Boyko OV; Shipilova NN; Kabaeva AR; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):99-103. PubMed ID: 34387455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
    Manouchehrinia A; Tanasescu R; Tench CR; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):324-31. PubMed ID: 25935887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.